Literature DB >> 23686031

Changing associations between cognitive impairment and imaging in multiple sclerosis as the disease progresses.

Sophia A Penny1, Mary M Summers, Josephine K Swanton, Lisa Cipolotti, David H Miller, Maria A Ron.   

Abstract

The authors explored cross-sectional associations between MRI parameters (lesion metrics, brain volumes, magnetization transfer ratio histograms, and metabolite concentrations) and cognition in 61 patients who experienced clinically-isolated syndromes (CIS) 7 years earlier. IQ decline and poorer overall cognition were associated with T2 white-matter lesions, and slow information-processing with both T2 lesions and gray-matter atrophy. In a previous study of the same cohort, gray-matter atrophy measured shortly after CIS failed to predict development of cognitive impairment years later. Our findings suggest that gray-matter pathology, reflected by atrophy measurements, becomes increasingly important in determining cognition as MS progresses.

Entities:  

Mesh:

Year:  2013        PMID: 23686031     DOI: 10.1176/appi.neuropsych.11090218

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  3 in total

Review 1.  Quantitative magnetization transfer imaging in relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.

Authors:  Elizabeth N York; Michael J Thrippleton; Rozanna Meijboom; David P J Hunt; Adam D Waldman
Journal:  Brain Commun       Date:  2022-04-04

2.  Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers.

Authors:  Danko Coric; Lisanne J Balk; Merike Verrijp; Anand Eijlers; Menno M Schoonheim; Joep Killestein; Bernard Mj Uitdehaag; Axel Petzold
Journal:  Mult Scler       Date:  2017-02-01       Impact factor: 6.312

3.  Psychiatric disorders revealing multiple sclerosis after 20 years of evolvement.

Authors:  Aicha Slassi Sennou; Saïd Boujraf; Mohammed Faouzi Belahsen; Ouafae Messouak
Journal:  J Neurosci Rural Pract       Date:  2014-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.